CD274 and breast cancer: On the other hand, we reported a comprehensive analysis in BC patients that demonstrated that PD+, PD-L1+ and cAMP+ were associated with worse prognosis and that the most frequent mutations were those identified with the dbSNP_ID rs1042522 and rs1058808, with a frequency of 83.3%.